The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
The FIFA World Cup 2026 is set to become the biggest and most financially rewarding…
The Indian Council of Agricultural Research (ICAR) has launched the 'Oilseeds Kisaan Mitra' which is…
Jaspal Rana who was country's one of the greatest shooters and most respected coaches, he…
1. Oilseeds Kisaan Mitra – India’s First WhatsApp AI Advisory Overview ICAR introduced Oilseeds Kisaan…
As India may not be a regular participant at the FIFA World Cup Competition but…
The World Day Against Child Labour is observed worldwide every year on 12th of June…